
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PTN CRISPR/Cas9 KO Plasmid (m2) | sc-422498-KO-2 | 20 µg | $397.00 |
Ptn encodes pleiotrophin (PTN), a secreted heparin-binding growth factor that modulates cell–cell and cell–matrix communication during development and tissue remodeling. PTN signals through interactions with receptor protein tyrosine phosphatases and other surface partners to influence phosphorylation cascades, neurite outgrowth, cell migration, and survival programs, including MAPK/ERK- and PI3K/AKT-linked processes. In mouse models, PTN is implicated in neurodevelopmental patterning, angiogenic responses, and regulation of inflammatory microenvironments, with altered expression reported across contexts of injury and proliferative signaling. These functions make Ptn a useful node for dissecting extracellular growth factor inputs that shape lineage behavior, synaptic connectivity, and stromal–immune crosstalk.
PTN CRISPR/Cas9 KO Plasmid (m2) is a pool of plasmids designed for targeted disruption of the Ptn gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Ptn together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Ptn open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PTN protein expression.
This CRISPR knockout system enables efficient generation of Ptn-deficient cell models for investigation of PTN signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.